Paper42904151PubMed
Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review.
Omidi Sarajar B and 4 others. Cancer Manag Res, 2026.
Cite this record
ConductScience Library. Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review. Papers, record 42904151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42904151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review.
- Journal
- Cancer Manag Res
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-22
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30944622 | Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30944622 | PubMed |
| 2 | 22540333 | Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression. | J Obstet Gynaecol Res | 2012 | https://conductscience.org/library/papers/22540333 | PubMed |
| 3 | 34707776 | Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34707776 | PubMed |
| 4 | 21415163 | Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. | Cancer Res | 2011 | https://conductscience.org/library/papers/21415163 | PubMed |
| 5 | 41528114 | Cancer statistics, 2026. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/41528114 | PubMed |
| 6 | 40906543 | Synergistic Enhancement of Cisplatin Anticancer Efficacy by Photobiomodulation Therapy: A Systematic Review. | Photobiomodul Photomed Laser Surg | 2025 | https://conductscience.org/library/papers/40906543 | PubMed |
| 7 | 40387464 | Targeting Cancer Stem Cells and Hedgehog Pathway: Enhancing Cisplatin Efficacy in Ovarian Cancer With Metformin. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40387464 | PubMed |
| 8 | 35339109 | Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35339109 | PubMed |
| 9 | 31032880 | Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/31032880 | PubMed |
| 10 | 33809479 | Strategies for Cancer Treatment Based on Photonic Nanomedicine. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/33809479 | PubMed |
| 11 | 33319669 | Resistance to Intervention: Paclitaxel in Breast Cancer. | Mini Rev Med Chem | 2021 | https://conductscience.org/library/papers/33319669 | PubMed |
| 12 | 27118574 | Combinational strategies of metformin and chemotherapy in cancers. | Cancer Chemother Pharmacol | 2016 | https://conductscience.org/library/papers/27118574 | PubMed |
| 13 | 23228696 | Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel. | Biochem Pharmacol | 2013 | https://conductscience.org/library/papers/23228696 | PubMed |
| 14 | 24096736 | Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. | Mol Cell Biochem | 2014 | https://conductscience.org/library/papers/24096736 | PubMed |
| 15 | 29869309 | Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy. | AAPS PharmSciTech | 2018 | https://conductscience.org/library/papers/29869309 | PubMed |
| 16 | 39225830 | Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39225830 | PubMed |
| 17 | 23707609 | Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. | Toxicol Appl Pharmacol | 2013 | https://conductscience.org/library/papers/23707609 | PubMed |
| 18 | 31029218 | Paclitaxel. | Profiles Drug Subst Excip Relat Methodol | 2019 | https://conductscience.org/library/papers/31029218 | PubMed |
| 19 | 40505600 | The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: A systematic review and Meta-analysis. | Transl Oncol | 2025 | https://conductscience.org/library/papers/40505600 | PubMed |
| 20 | 37893061 | Regulation of Protein-Induced Apoptosis and Autophagy in Human Hepatocytes Treated with Metformin and Paclitaxel In Silico and In Vitro. | Biomedicines | 2023 | https://conductscience.org/library/papers/37893061 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42904151
GET https://conductscience.org/api/papers/v1/42904151/references?page=2